Appraisal of danazol prophylaxis for hereditary angioedema

Allergy and Asthma Proceedings

Volumn 29, Issue 3, 2008, Pages 225-231

  Craig, Timothy J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Adverse events; Androgens; Angioedema; C 1 esterase inhibitor deficiency; Danazol; Hereditary angioedema; Therapeutics

Indexed keywords

BRADYKININ; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; KALLIKREIN;

ANGIONEUROTIC EDEMA; ATHEROSCLEROSIS; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; FEMALE; GENETICS; GONADAL DISEASE; HUMAN; IMMUNOLOGY; LIVER ADENOMA; LIVER TUMOR; MALE; PATHOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW;

ADENOMA, LIVER CELL; ANGIOEDEMA, HEREDITARY; ATHEROSCLEROSIS; BRADYKININ; COMPLEMENT C1 INHIBITOR PROTEIN; DANAZOL; FEMALE; HUMANS; KALLIKREINS; LIVER NEOPLASMS; MALE; QUALITY OF LIFE; VIRILISM;

EID: 46649095603     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3107     Document Type: Review

References (44)

1. Agostoni A, Aygören-Pürsün E, Binkley KE, et al. Hereditary and acquired angioedema: Problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51-S131, 2004.
2. Frank MM. Hereditary angioedema: The clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 26:653-668, 2006.
3. Fay A, and Abinun M. Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency). J Clin Pathol 55:266-270, 2002.
4. Nzeako UC, Frigas E, and Tremaine WJ. Hereditary angioedema: A broad review for clinicians. Arch Intern Med 161: 2417-2429, 2001.
5. Davis AE III. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am 26:633-651, 2006.
6. Bork K, Hardt J, Schicketanz KH, and Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med. 163:1229-1235, 2003.
7. Cicardi M, and Agostoni A. Hereditary angioedema. N Engl J Med 334:1666-1667, 1996.
8. Huang SW. Results of an on-line survey of patients with hereditary angioedema. Allergy Asthma Proc 25:127-131, 2004.
9. Sofia S, Casali A, and Bolondi L. Sonographic findings in abdominal hereditary angioedema. J Clin Ultrasound 27:537-540, 1999.
10. Sim TC, and Grant JA. Hereditary angioedema: Its diagnostic and management perspectives. Am J Med 88:656-664, 1990.
11. Schneider L, Lumry W, Vegh A, et al. Critical role of kallikrein in hereditary angioedema pathogenesis: A clinical trial of ecallantide, a novel kallikrein inhibitor. J Allergy Clin Immunol 120:416-422, 2007.
12. Waytes AT, Rosen FS, and Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 334:1630-1634, 1996.
13. Levi M, Choi F, Picavet C, and Hack CE. Self-administration of Cl-inhibitor concentrate in patients with hereditary or acquired angioedema caused by Cl-inhibitor deficiency. J Allergy Clin Immunol 117:904-908, 2006.
14. Ebo DG, and Stevens WJ. Hereditary angioneurotic edema: Review of the literature. Acta Clin Belg 55:22-29, 2000.
15. Farkas H, Harmat G, Füst G, et al. Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol 13:153-161, 2002.
16. Zuraw BL. Diagnosis and management of hereditary angioedema: An American approach. Transfus Apher Sci 29:239-245, 2003.
17. Bracho FA. Hereditary angioedema. Curr Opin Hematol 12: 493-498, 2005.
18. Sachse MM, Khachemoune A, Guldbakke KK, and Kirschfink M. Hereditary angioedema. J Drugs Dermatol 5:848-852, 2006.
19. Weiler JM, Quinn SA, Woodworth GG, et al. Does heparin prophylaxis prevent exacerbations of hereditary angioedema? J Allergy Clin Immunol 109:995-1000, 2002.
20. Danazol Prescribing Information. 2006. Available online at www.drugs.com/pro/danocrine.html; last accessed November 28, 2007.
21. Széplaki G, Varga L, Valentin S, et al. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol 115:864-869, 2005.
22. Hosea SW, Santaella ML, Brown EJ, et al. Longterm therapy of hereditary angioedema with danazol. Ann Intern Med 93:809-812, 1980.
23. Gelfand JA, Sherins RJ, Alling DW, and Frank MM. Treatment of hereditary angioedema with danazol: Reversal of clinical and biochemical abnormalities. N Engl J Med 295:1444-1448, 1976.
24. Cicardi M, Berti E, Caputo V, et al. Idiopathic capillary leak syndrome: Evidence of CD8-positive lymphocytes surrounding damaged endothelial cells. J Allergy Clin Immunol 99:417-419, 1997.
25. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: Consensus document. Clin Exp Immunol 139:379-394, 2005.
26. Plano VF. Danazol: Review of recent studies. J Am Osteopath Assoc 79:530, 1980.
27. Bork K, Zingale L, Farkas H, et al. Side effects of long-term treatment with danazol and stanozolol in hereditary angioedema. J Allergy Clin Immunol 119:3275, 2007 (Abs).
28. Helsing P, and Nielsen EW. Ruby laser treatment of congenital melanocytic naevi - A pessimistic view. Acta Dermato Venereologica 86:235-237, 2006.
29. Crampon D, Barnoud R, Durand M, et al. Danazol therapy: An unusual aetiology of hepatocellular carcinoma. J Hepatol 29: 1035-1036, 1998.
30. Bork K, Pitton M, Harten P, and Koch P. Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet 353:1066-1067, 1999.
31. Bork K, and Schneiders V. Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. J Hepatol 36:707-709, 2002.
32. Hayashi T, Takahashi T, Minami T, et al. Fatal acute hepatic failure induced by danazol in a patient with endometriosis and aplastic anemia. J Gastroenterol 36:783-786, 2001.
33. Cicardi M, Bergamaschini L, Tucci A, et al. Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives. J Allergy Clin Immunol 72:294-298, 1983.
34. Bowen T, Cicardi M, Farkas H, et al. Canadian 2003 International consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol 114:629-637, 2004.
35. Zurlo JJ, and Frank MM. The long-term safety of danazol in women with hereditary angioedema. Fertil Steril 54:64-72, 1990.
36. retza JA, Novey HS, Vaziri ND, and Warner AS. Hypertension: A complication of danazol therapy. Arch Intern Med 140:1379-1380, 1980.
37. Shah A, Roberts T, McQueen IN, et al. Danazol and benign intracranial hypertension. Br Med J (Clin Res Ed) 294:1323, 1987.
38. Corno M, Vallar G, Scarlato G, and Meola G. Danazol and internal carotid artery thrombosis. Eur Neurol 29:235-237, 1989.
39. Alvarado RG, Liu JY, and Zwolak RM. Danazol and limb-threatening arterial thrombosis: two case reports. J Vasc Surg 34:1123-1126, 2001.
40. Sloane D, Lee C, and Sheffer A. Hereditary Angioedema: Safety of long term stanozolol therapy. J Allergy Clin Immunol 120: 654-658, 2007.
41. Church J. Oxandrolone treatment of childhood hereditary angioedema. Ann Allergy Asthma Immunol 92:377-378, 2004.
42. Banerji A, Sloane D, and Sheffer A. Attenuated androgens for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 100:519-822, 2008.
43. Zuraw B. Hereditary angioedema: A current state-of-the review: Short and long term treatment of hereditary angioedema: Out with the old and in with the new. Ann Allergy Asthma Immunol 100:513-518, 2008.
44. Bernstein J. Hereditary angioedema: A current state-of-the-art review: Current status of emerging therapies. Ann Allergy Asthma Immunol 100:S41-S46, 2008.